Antineoplastic Therapy and Immunotherapy Course 2022 IR Nurse

April 11, 2022 to May 2, 2022

This four-day course is designed to address the needs of the nursing and other oncology professionals in relation to chemotherapy and biological therapies.  It includes information on current and investigational pharmacotherapy, safe handling, administration of antineoplastic agents, and various issues concerning the management of patients receiving cancer therapy.

Target Audience

UPMC Interventional Radiation nurses who administer antineoplastic medications

Learning Objectives

Learning Objectives

 

After participation in this activity, the learner will be able to:

  • Discuss the expectations related to class content and the participant’s professional responsibilities
  • Discuss the roles of chemotherapy and biotherapy in the treatment of cancer
  • Recall the pharmacology of different classes of antineoplastic or supportive therapies
  • Recognize side effects and organ toxicities that patients may experience while receiving antineoplastic or supportive therapies
  • Discuss management strategies for patients receiving antineoplastic or supportive therapies, including the prevention and treatment of toxicities and side effects
  • Identify interventions to prevent chemotherapy errors
  • Demonstrate that learning has occurred by achieving at least an 80% on the final exam

Additional Information

AttachmentSize
PDF icon AIS- IR Nurses Chemo fall 2021.pdf81.6 KB
Course summary
Available credit: 
  • 14.25 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 14.25 Attendance
Course opens: 
04/07/2022
Course expires: 
05/31/2022
Event starts: 
04/11/2022 - 8:00am EDT
Event ends: 
05/02/2022 - 5:00pm EDT
Add to calendar: 
UPMC Hillman Cancer Center
Pittsbugh, PA
United States

This course will be held virtually via UPMC Microsoft TEAMS

Mary Kate Ayers, MSN, RN, OCN
Senior Clinician, 5 Main
UPMC Shadyside Hospital

Amy DiMaggio, MSN, RN, CMSRN, OCN
Clinical Education Specialist
UPMC Hillman Cancer Center

Timothy George, PharmD, BCOP
Clinical Pharmacy Specialist
UPMC Hillman Cancer Center

Paul Huffman, PharmD
Oncology Pharmacist
UPMC Hillman Cancer Center

Nicole Kahler, DNP, CRNP, AOCNP
Nurse Practitioner
University of Pittsburgh Physicians

Becky McClelland, MSN-Ed, RN, OCN
Clinical Education Specialist
UPMC Hillman Cancer Center

Brian Miller, PharmD
Manager, Investigational Drug Service Pharmacy
UPMC Hillman Cancer Center

Alyssa Owens, MPAS, PA-C
Physician Assistant
UPMC Hillman Cancer Center

Brittni Prosdocimo, MSN, RN, BMTCN
Advanced Clinical Education Specialist
UPMC Hillman Cancer Center

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.

This activity is designated for 14.25  AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

The maximum number of hours awarded for this Continuing Nursing Education activity is 14.25 contact hours.

To receive 14.25  Contact Hours, the learner must sign in, attend the entire activity, pass course test with a score of 80% or greater and complete the activity evaluation.

Available Credit

  • 14.25 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 14.25 Attendance
Please login or register to take this course.